George Coukos
Researcher Next ID · RN-029825
Researcher · Immunology and Microbiology
Brussels, Switzerland
- Works count
- 882
- Citation count
- 67,425
- H-index
- 113
- i10-index
- 366
Research interests
Publications
Interpretation of T cell states from single-cell transcriptomics data using reference atlases
Nature Communications · 2021 · 10.1038/s41467-021-23324-4
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Journal for ImmunoTherapy of Cancer · 2020 · https://doi.org/10.1136/jitc-2019-000337
Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction
Cell · 2020 · https://doi.org/10.1016/j.cell.2020.09.015
Disturbed mitochondrial dynamics in CD8+ TILs reinforce T cell exhaustion
Nature Immunology · 2020 · 10.1038/s41590-020-0793-3
Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors
Cancer Cell · 2019 · 10.1016/j.ccell.2019.05.004
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
Nature Reviews Clinical Oncology · 2019 · https://doi.org/10.1038/s41571-019-0218-0
Consensus guidelines for the use and interpretation of angiogenesis assays
Angiogenesis · 2018 · 10.1007/s10456-018-9613-x
Interrogating open issues in cancer precision medicine with patient-derived xenografts
Nature reviews. Cancer · 2017 · https://doi.org/10.1038/nrc.2016.140
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
Nature reviews. Cancer · 2015 · https://doi.org/10.1038/nrc4019
Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers
Cancer Cell · 2015 · 10.1016/j.ccell.2015.09.006
Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
Nature Medicine · 2014 · 10.1038/nm.3541
Deciphering and Reversing Tumor Immune Suppression
Immunity · 2013 · 10.1016/j.immuni.2013.07.005
Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors
Cancer Research · 2013 · 10.1158/0008-5472.can-12-4100
T-Regulatory Cells: Key Players in Tumor Immune Escape and Angiogenesis
Cancer Research · 2012 · 10.1158/0008-5472.can-11-3687
Cancer immunotherapy comes of age
Nature · 2011 · https://doi.org/10.1038/nature10673
Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis
Gynecologic Oncology · 2011 · 10.1016/j.ygyno.2011.09.039
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
Nature · 2011 · 10.1038/nature10169
Rethinking ovarian cancer: recommendations for improving outcomes
Nature reviews. Cancer · 2011 · https://doi.org/10.1038/nrc3144
Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments
Blood · 2009 · 10.1182/blood-2009-03-208249
Modulation of the antitumor immune response by complement
Nature Immunology · 2008 · 10.1038/ni.1655
The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis
Nature Cell Biology · 2008 · 10.1038/ncb1681
Laser-capture microdissection
Nature Protocols · 2006 · 10.1038/nprot.2006.85
microRNAs exhibit high frequency genomic alterations in human cancer
Proceedings of the National Academy of Sciences · 2006 · 10.1073/pnas.0508889103
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
Nature Medicine · 2004 · https://doi.org/10.1038/nm1093
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
New England Journal of Medicine · 2003 · https://doi.org/10.1056/nejmoa020177
Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
PubMed · 2001
Current projects
No projects listed.